Turn Biotechnologies Expands Epigenetic Therapies with ARMMs Technology Acquisition Turn Biotechnologies has acquired ARMMs technology to enhance its epigenetic reprogramming therapies. This strategic move aims to broaden the delivery of treatments to various tissues.

Turn Biotechnologies Expands Epigenetic Therapies with ARMMs Technology Acquisition #USA #Mountain_View #Turn_Biotechnologies #ARMMs #eTurna